Advertisement
Journal Home
Search for

Volume 59, Issue 3, Pages 308-314 (March 2006)


View previous. 14 of 17 View next.

A new method for assessing drug causation provided agreement with experts' judgment

Yannick Arimoneab, Bernard BégaudabCorresponding Author Informationemail address, Ghada Miremont-Salaméac, Annie Fourrier-Réglatab, Mathieu Molimardab, Nicholas Mooreab, Françoise Haramburuac

Accepted 1 August 2005.

Abstract 

Background and Objective

The many methods proposed for causality assessment of adverse drug reaction (ADR) generally rely on algorithms. They have no clear relationship to probabilities, however, a situation we attempted to improve.

Study Design and Setting

Thirty ADR cases corresponding to 32 suspect drugs were randomly selected from the French pharmacovigilance database. The statistical weighting was performed by using a multilinear regression with logit(p) as the dependent variable and seven judgment criteria as independent variables. The best model (i.e., giving the best correlation with the gold standard) was retained for the new causality assessment method.

Results

The weights [logit(p)] for the 21 choices, on average three for each of the seven criteria, ranged from −3.95 to 0.86, secondarily rounded to multiples of 0.5. The correlation between the probability obtained from the final method and the gold standard was quite good (R2 = .92).

Conclusion

This method based on the rational weighting of seven causality criteria is straightforward to use and provides very good agreement with experts' judgment. Moreover, unlike most classical algorithms, it respects one basic rule of probabilities—namely, a symmetrical probability distribution for drug causation around the .5 neutral position (maximum uncertainty).

a INSERM U657, 33076 Bordeaux Cedex, France

b Université Victor Segalen Bordeaux 2, Département de Pharmacologie, Case 36-146, Rue Léo Saignat, 33076 Bordeaux Cedex, France

c CHU de Bordeaux, Hôpital Pellegrin, Centre de Pharmacovigilance, 33076 Bordeaux Cedex, France

Corresponding Author InformationCorresponding author. Tel.: +33-557-571561; fax: +33-557-574660.

PII: S0895-4356(05)00333-1

doi:10.1016/j.jclinepi.2005.08.012


View previous. 14 of 17 View next.

Advertisement